Target intelligence / Profile preview

ITFG2 antisense RNA 1 (ITFG2-AS1)

Target
ITFG2-AS1
Molecular classification
long non-coding RNA (lncRNA), antisense RNA
01

Overview

ITFG2 antisense RNA 1 is a long non-coding RNA gene on human chromosome 12, annotated as an antisense transcript. It is part of the molecular class of antisense RNAs, which act on the opposite strand from a protein-coding locus and can regulate gene expression of neighboring or overlapping genes. ITFG2-AS1 does not encode a protein, and functional information is limited; it is not currently classified as a drug or therapeutic target in pharmacological databases.

Other names
CACNA1C-AS1CACNA1C-AS2CACNA1C antisense RNA 1CACNA1C antisense RNA 2ITFG2-AS1CACNA1C antisense RNA 1 (non-protein coding)
02

Mechanism of action

Not applicable; no drugs target ITFG2-AS1 directly

03

Biological functions

Regulation of gene expressionEpigenetic modificationTranscriptional interferenceSpecific biological functions for ITFG2-AS1 are not well-established in public databases
04

Disease associations

No direct, well-established disease associations for ITFG2-AS1Potential associations for related alias CACNA1C-AS1 with Timothy SyndromePotential associations for related alias CACNA1C-AS1 with Long QT Syndrome 8 (likely via regulation of CACNA1C)ITFG2-AS1 itself has not been confirmed as a disease mediator

Beyond the preview

Go deeper on ITFG2 antisense RNA 1 (ITFG2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ITFG2 antisense RNA 1 (ITFG2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call